(Q35917064)

11 August 2017

1 reference

title

Trospium chloride in the management of overactive bladder (English)

1 reference

11 August 2017

Eric S Rovner

1

1 reference

11 August 2017

publication date

1 January 2004

1 reference

11 August 2017

1 reference

11 August 2017

volume

64

1 reference

11 August 2017

issue

21

1 reference

11 August 2017

page(s)

2433-2446

1 reference

Prevalence and burden of overactive bladder in the United States

11 August 2017

cites work

1 reference

12 December 2020

Current and future pharmacological treatment for overactive bladder

1 reference

12 December 2020

Importance of pharmacological and physicochemical properties for tolerance of antimuscarinic drugs in the treatment of detrusor instability and detrusor hyperreflexia--chances for improvement of therapy

1 reference

12 December 2020

Trospium chloride--an effective drug in the treatment of overactive bladder and detrusor hyperreflexia

1 reference

12 December 2020

Effects of tolterodine, trospium chloride, and oxybutynin on the central nervous system

1 reference

12 December 2020

Effect of trospium chloride on gastrointestinal motility in humans

1 reference

12 December 2020

Effects of two anticholinergic drugs, trospium chloride and biperiden, on motility and evoked potentials of the oesophagus

1 reference

12 December 2020

Definition and epidemiology of overactive bladder

1 reference

12 December 2020

Muscarinic receptor subtypes and management of the overactive bladder

1 reference

12 December 2020

Estimated economic costs of overactive bladder in the United States

1 reference

12 December 2020

Influences of trospium chloride and oxybutynin on quantitative EEG in healthy volunteers

1 reference

12 December 2020

The standardisation of terminology in nocturia: report from the Standardisation Sub-committee of the International Continence Society

1 reference

12 December 2020

Comparison of the effects of various spasmolytic drugs on isolated human and porcine detrusor smooth muscle

1 reference

12 December 2020

Risk of delirium with concomitant use of tolterodine and acetylcholinesterase inhibitors

1 reference

12 December 2020

Management of overactive bladder

1 reference

12 December 2020

Responses of isolated normal human detrusor muscle to various spasmolytic drugs commonly used in the treatment of the overactive bladder

1 reference

12 December 2020

Trospium chloride: an effective option for medical treatment of bladder overactivity.

1 reference

12 December 2020

Trospium chloride: A quaternary amine with unique pharmacologic properties

1 reference

12 December 2020

Randomised, double-blind study of the effects of oxybutynin, tolterodine, trospium chloride and placebo on sleep in healthy young volunteers

1 reference

12 December 2020

New roles for muscarinic receptors in the pathophysiology of lower urinary tract symptoms

1 reference

12 December 2020

Discussion: functional role of M(1), M(2), and M(3) muscarinic receptors in overactive bladder

1 reference

12 December 2020

How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study

1 reference

12 December 2020

[High-dose trospium chloride in therapy of detrusor hyperreflexia]

1 reference

12 December 2020

[Intravesical instillation of trospium chloride, oxybutynin and verapamil for relaxation of the bladder detrusor muscle. A placebo controlled, randomized clinical test]

1 reference

12 December 2020

Effect of trospium chloride on urodynamic parameters in patients with detrusor hyperreflexia due to spinal cord injuries. A multicentre placebo-controlled double-blind trial

1 reference

12 December 2020

Trospium chloride improves overactive bladder symptoms: a multicenter phase III trial

1 reference

12 December 2020

Pharmacologic perspective on the physiology of the lower urinary tract

1 reference

12 December 2020

Trospium chloride versus oxybutynin: a randomized, double-blind, multicentre trial in the treatment of detrusor hyper-reflexia

1 reference

12 December 2020

Safety and tolerance of trospium chloride in the high dose range

1 reference

12 December 2020

Controlled, double-blind, multicentre clinical trial to investigate long-term tolerability and efficacy of trospium chloride in patients with detrusor instability

1 reference

12 December 2020

Clinical Pharmacokinetics of Drugs Used to Treat Urge Incontinence

1 reference

12 December 2020

Efficacy of trospium chloride in patients with detrusor instability: a placebo-controlled, randomized, double-blind, multicentre clinical trial

1 reference

12 December 2020

Inhibitory effects of trospium chloride on cytochrome P450 enzymes in human liver microsomes

1 reference

12 December 2020

Overview consensus statement

1 reference

12 December 2020

Trospium chloride in patients with detrusor overactivity: meta-analysis of placebo-controlled, randomized, double-blind, multi-center clinical trials on the efficacy and safety of 20 mg trospium chloride twice daily

1 reference

12 December 2020

Trospium chloride for the treatment of detrusor instability in children

1 reference

12 December 2020

Ultrasound studies of the effect of trospium chloride on gall-bladder kinetics

1 reference

12 December 2020

Determination of the bioavailability of the quaternary compound trospium chloride in man from urinary excretion data

1 reference

12 December 2020

10.2165/00003495-200464210-00005

Identifiers

DOI

1 reference

Dimensions Publication ID

11 August 2017

1021756284

0 references

1 reference